about
Guidelines for the use and interpretation of assays for monitoring autophagyThe nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.Application of metabolomics in drug resistant breast cancer researchCannibalism, cell survival, and endocrine resistance in breast cancerAutophagy and endocrine resistance in breast cancerG-DOC Plus - an integrative bioinformatics platform for precision medicine.TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signalingInfluence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer preventionAntiestrogens, aromatase inhibitors, and apoptosis in breast cancerEnhancing reproducibility in cancer drug screening: how do we move forward?Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysis.Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.Iterative normalization of cDNA microarray data.BADGE: a novel Bayesian model for accurate abundance quantification and differential analysis of RNA-Seq data.BSSV: Bayesian based somatic structural variation identification with whole genome DNA-seq dataOptimized multilayer perceptrons for molecular classification and diagnosis using genomic data.Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.Approaches to working in high-dimensional data spaces: gene expression microarrays.A ground truth based comparative study on clustering of gene expression data.AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.Motif-directed network component analysis for regulatory network inference.caBIG VISDA: modeling, visualization, and discovery for cluster analysis of genomic data.Reverse engineering module networks by PSO-RNN hybrid modelingGene module identification from microarray data using nonnegative independent component analysisCross phenotype normalization of microarray data.Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.Knowledge-guided gene ranking by coordinative component analysis.The role of preclinical animal models in breast cancer drug development.Reconstruction of gene regulatory modules in cancer cell cycle by multi-source data integration.Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathwaysmAPC-GibbsOS: an integrated approach for robust identification of gene regulatory networks.Mathematical models of the transitions between endocrine therapy responsive and resistant states in breast cancer.DDN: a caBIG® analytical tool for differential network analysisVAV3 mediates resistance to breast cancer endocrine therapy.Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.Multilevel support vector regression analysis to identify condition-specific regulatory networksCadmium mimics the in vivo effects of estrogen in the uterus and mammary gland.
P50
Q21996341-67B4C048-4A7F-4A55-9DD9-67EC328100B0Q24815528-2CD39C19-6ECE-4410-9AE1-F123542FBFA2Q26866291-3BB941B0-5410-4A4B-B487-306D593FFDEFQ26995731-9F5E4181-6DE0-43EE-95EB-A608CD46580EQ27023375-27BD439E-6DD5-4799-9076-A74C755B75BDQ27319225-B82469F2-D1D0-49CE-839E-240DC574787BQ28115071-EAB3F9FC-7958-4644-9280-0113A6238D5CQ28258801-582524FC-8FEB-4FA4-A941-40348DD2B3BFQ28268250-E2F2E555-CF29-4F2F-892C-74266327169AQ30405622-1F534762-23C3-4629-AB74-EC01972B2C3EQ30417594-DC1791EE-18A3-49E1-959D-B696B3385259Q30419997-9C7916E0-C4E4-4ACD-B2FF-AE80AAC0BDF0Q30432099-254D8928-086E-465F-AEDA-544B218C35F7Q30441028-4B07ACD3-A13E-4A17-B8D9-10B755AD5B85Q30686050-6F4AC920-45D3-41F8-A89D-39C32175C6DAQ30855028-11656B11-550E-4623-B35C-6393C375E52DQ30883476-B8043207-7A58-4561-96BF-94A981B600BDQ31029221-C9ECBE07-B0B3-444D-B2E9-7B4035DE86EAQ31074315-85603218-E975-422A-95C1-27372E0783F6Q31140694-DEDDA6C1-8195-4ACD-B8B3-D1EDDFC71F54Q31147056-C9CCC4E4-2F8A-454D-ADC0-A17269A0B3BAQ31156840-CC7E8B0E-2B54-470D-9E44-29EE4F2766DEQ33241980-D17753A0-142C-4F72-AFEA-26E22D94816CQ33322210-2D38AE95-241A-4422-B41F-F6FEBF575EC4Q33370429-52B199E2-E0F8-4D3A-B202-48E099319B34Q33481221-E34A7225-491C-4BAC-AFF9-4F8796D1A0F3Q33516560-B91A372E-ACB6-4E76-B6F5-C1EFC45E4527Q33520897-6056EE42-DF39-4F75-93C7-49FB0937F696Q33523022-9FE49609-0749-4E04-B4D5-3F92CF80BE7AQ33547729-95285098-9750-4212-9FFE-4A2CDEF2AD82Q33555575-D8ECC6A4-3DBD-41D4-9D11-92C2FF235B5BQ33565567-E274C4D4-9EE5-4984-BF9D-183B2D0FBC86Q33584432-4175A565-3FAC-41BE-958E-61F44928810FQ33640925-2CE06172-F0AC-4D78-9525-12BF47E066E4Q33656026-E426241F-91EA-4BD4-B0F9-A99E86E24F03Q33812553-25732BA0-A7AF-4912-AE94-15360C090125Q33827037-7130990E-50F2-48BE-8E44-DFE715316B7CQ33857080-76F97E71-6660-459E-A0DB-31F10ED955C4Q33857304-43206157-069C-4629-A3D5-7D888639EAD0Q33967143-D4AA3FDE-4E89-4CD1-9B07-C9D5AF4FAF33
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Robert Clarke
@ast
Robert Clarke
@en
Robert Clarke
@es
Robert Clarke
@fr
Robert Clarke
@nl
Robert Clarke
@sl
روبرت كلارك
@ar
type
label
Robert Clarke
@ast
Robert Clarke
@en
Robert Clarke
@es
Robert Clarke
@fr
Robert Clarke
@nl
Robert Clarke
@sl
روبرت كلارك
@ar
altLabel
Bob
@en
prefLabel
Robert Clarke
@ast
Robert Clarke
@en
Robert Clarke
@es
Robert Clarke
@fr
Robert Clarke
@nl
Robert Clarke
@sl
روبرت كلارك
@ar
P1053
A-6485-2008
P106
P1153
56551716900
P1960
BgsjeHMAAAAJ
P2038
Robert_Clarke2
P21
P2798
P31
P3829
P496
0000-0002-9278-0854